English(EN) Eating disorders are on the rise. GLP-1s could make things worse.

饮食失调症激增71%，专家警告GLP-1类药物可能加剧危机

作者 PulseAugur 编辑部 · [1 个来源] · 2026-10-30 09:00

最新报告显示，饮食失调症显著增加，神经性厌食症和神经性贪食症的发病率在1990年至2023年间上升了71%。专家们担心，流行的GLP-1类减肥药物可能会加剧这些病情，因为据报道一些患有饮食失调症的人正在滥用它们。饮食失调症的真实患病率可能高于报告的数字，预计病例将持续上升。 AI

排序理由文章讨论了GLP-1类药物与饮食失调症相关的趋势和专家担忧，而非具体事件。

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 1 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Commentary; 文章讨论了GLP-1类药物与饮食失调症相关的趋势和专家担忧，而非具体事件。
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: other; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: Low; Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness: Breaking (< 6h); Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

MIT Technology Review TIER_1 English(EN) · Jessica Hamzelou · 2026-10-30 09:00

饮食失调症正在上升。GLP-1s 可能会让情况变得更糟。

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa an…